GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » Pre-Tax Income

Karo Pharma AB (Karo Pharma AB) Pre-Tax Income : $2.1 Mil (TTM As of Jun. 2022)


View and export this data going back to . Start your Free Trial

What is Karo Pharma AB Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Karo Pharma AB's pretax income for the three months ended in Jun. 2022 was $0.0 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2022 was $2.1 Mil. Karo Pharma AB's pretax margin was %.


Karo Pharma AB Pre-Tax Income Historical Data

The historical data trend for Karo Pharma AB's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Pre-Tax Income Chart

Karo Pharma AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.48 32.13 1.76 6.83 1.38

Karo Pharma AB Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.78 -1.11 6.36 -10.97 -

Competitive Comparison of Karo Pharma AB's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Karo Pharma AB's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's Pre-Tax Income falls into.



Karo Pharma AB Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Karo Pharma AB's Pretax Income for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=21.913+0+-20.122+0.023+-0.437
=1.4

Karo Pharma AB's Pretax Income for the quarter that ended in Jun. 2022 is calculated as


Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Karo Pharma AB  (OTCPK:KARBF) Pre-Tax Income Explanation

Karo Pharma AB's Pretax Margin for the quarter that ended in Jun. 2022 is calculated as

Pretax Margin=Pretax Income/Revenue
=0/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Karo Pharma AB Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Karo Pharma AB (Karo Pharma AB) Business Description

Traded in Other Exchanges
N/A
Address
Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire 06-25-2019